TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Patofysiologiska Laboratoriet i Västerås AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
275
|
237
|
222 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
65
|
21
|
5 |
| EBITDA |
55
|
21
|
5 |
| Total assets |
758
|
659
|
657 |
| Current assets |
758
|
659
|
657 |
| Current liabilities |
17
|
16
|
14 |
| Equity capital |
741
|
643
|
644 |
| - share capital |
101
|
95
|
98 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
97.8%
|
97.6%
|
98.0% |
| Turnover per employee |
275
|
237
|
222 |
| Profit as a percentage of turnover |
23.6%
|
8.9%
|
2.3% |
| Return on assets (ROA) |
8.6%
|
3.2%
|
0.8% |
| Current ratio |
4458.8%
|
4118.8%
|
4692.9% |
| Return on equity (ROE) |
8.8%
|
3.3%
|
0.8% |
| Change turnover |
20
|
22
|
5 |
| Change turnover % |
8%
|
10%
|
2% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.